Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report. [PDF]
AACE Endocrinol DiabetesTakebe S +4 more
europepmc +1 more source
Vitamin D for type 2 diabetes prevention: cost-effective, but not yet cost-saving. [PDF]
Lancet Reg Health AmZhang J, Zhan X, Li T.
europepmc +1 more source
Efficacy and safety of doxercalciferol (1α hydroxyvitamin D<sub>2</sub>) on spine and femur bone mineral density in postmenopausal osteopenic women. [PDF]
Front Endocrinol (Lausanne)Gallagher JC, Mazess R.
europepmc +1 more source
Denosumab increased bone mineral density but caused marked serum calcium fluctuations in a patient undergoing peritoneal dialysis. [PDF]
CEN Case RepYamada S +4 more
europepmc +1 more source
Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT. [PDF]
The effects of an active vitamin D analog, eldecalcitol (ELD), on bone mineral density (BMD), bone geometry, and biomechanical properties of the proximal femur were investigated by using clinical CT.
Shiraki, Masataka +4 more
core
Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications. [PDF]
Int J Mol SciNguyen TT +5 more
europepmc +1 more source
Multiple Occult Fractures at Hemodialysis Initiation in a Chronic Kidney Disease Patient: Diagnostic Value of MRI and Potential Role of Zinc Deficiency. [PDF]
CureusNakazawa R +4 more
europepmc +1 more source
Efficacy of 12-month romosozumab monotherapy or combination with eldecalcitol in patients with osteoporosis with and without chronic kidney disease: A real-world retrospective study. [PDF]
Biomed RepUchiyama T +3 more
europepmc +1 more source
Trends and prescribing patterns of antiosteoporosis medicines in Chinese patients: a real-world retrospective study. [PDF]
Aging Clin Exp ResZhang S +6 more
europepmc +1 more source